| Collection |
D4 : TTD |
| Chemical Name |
Dinaciclib ( From PubChem : D I N A C I C L I B ) |
| FDA |
NPC |
WHO |
Indian |
Australia |
China |
Traditional
Herbal |
Clinical
Trail |
| Not | Not | Not | Not | Not | Not | Not | Not |
|
Molecular
Weight |
Hydrogen Bond
Donor Count |
Hydrogen Bond
Acceptor Count |
cLogP |
Lipinski Rule |
| 396.486 g/mol |
2 |
7 |
3.2116 |
True |
|
| Structure |
|
| InChI |
I n C h I = 1 S / C 2 1 H 2 8 N 6 O 2 / c 1 - 2 - 1 7 - 1 4 - 2 3 - 2 7 - 1 9 ( 2 2 - 1 3 - 1 6 - 6 - 5 - 9 - 2 5 ( 2 9 ) 1 5 - 1 6 ) 1 2 - 2 0 ( 2 4 - 2 1 ( 1 7 ) 2 7 ) 2 6 - 1 0 - 4 - 3 - 7 - 1 8 ( 2 6 ) 8 - 1 1 - 2 8 / h 5 - 6 , 9 , 1 2 , 1 4 - 1 5 , 1 8 , 2 2 , 2 8 H , 2 - 4 , 7 - 8 , 1 0 - 1 1 , 1 3 H 2 , 1 H 3 / t 1 8 - / m 0 / s 1 |
| InChIKey |
P I M Q W R Z W L Q K K B J - S F H V U R J K S A - N
|
| Links |
|
Gene
(3 /
11)
⊖ Less
|
| Source | Type | Unit | Value | Gene | PMID | Assay | Other | | TTD | Multitarget | CDK1 | | | Clinical trial target | | TTD | Inhibitor | CDK1 | | | Clinical trial target | | TTD | Drug(s) | CDK1 | | | Clinical trial target | | TTD | Multitarget | CDK2 | | | Clinical trial target | | TTD | Inhibitor | CDK2 | | | Clinical trial target | | TTD | Drug(s) | CDK2 | | | Clinical trial target | | TTD | Multitarget | CDK9 | | | Clinical trial target | | TTD | Inhibitor | CDK9 | | | Clinical trial target | | TTD | Drug(s) | CDK9 | | | Clinical trial target | | ChEMBL | Inhibition | - | | CDK2
| - |  | Target : CHEMBL301 | | ChEMBL | Inhibition | - | | CDK2
| - | | Target : CHEMBL301 |
|
| Download gene sets |
gmt, text, Detailed text
|
